• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SOFRADIM PRODUCTION SAS PARIETEX; MESH, SURGICAL, POLYMERIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SOFRADIM PRODUCTION SAS PARIETEX; MESH, SURGICAL, POLYMERIC Back to Search Results
Model Number PCO2015X
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Wound Dehiscence (1154); Abscess (1690); Adhesion(s) (1695); Unspecified Infection (1930); Inflammation (1932); Pain (1994); Sepsis (2067); Hernia (2240); Discomfort (2330); Obstruction/Occlusion (2422); Abdominal Distention (2601); Unspecified Tissue Injury (4559)
Type of Reportable Event Serious Injury
Event or Problem Description
The patient's attorney alleged a deficiency against the device.The product was used for therapeutic treatment of hernia.It was reported that after implant, the patient experienced recurrence, infection, abscess, adhesions, obstruction, pain, sepsis, severe adhesive disease, incarceration.Post-operative patient treatment included revision surgery, placement of wound vac.
 
Additional Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event or Problem Description
The patient's attorney alleged a deficiency against the device.The product was used for therapeutic treatment of hernia.It was reported that after implant, the patient experienced inflammation, abdominal distention, disability, recurrence, infection, abscess, adhesions, obstruction, pain, sepsis, severe adhesive disease, incarceration.Post-operative patient treatment included revision surgery, placement of wound vac, lysis of adhesions, exploratory laparotomy, resection of end ileostomy, abdominal washout, and medication.
 
Additional Manufacturer Narrative
Additional information: a2, a3, a4, b2, b5, b7, d4, h6 (patient codes), additional codes.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event or Problem Description
The patient's attorney alleged a deficiency against the device.The product was used for therapeutic treatment of a parastomal hernia.It was reported that after implant, the patient experienced wound dehiscence, pressure on right side, limited ability to bend and lift, inflammation, abdominal distention, disability, recurrence, infection, abscess, adhesions, obstruction, pain, sepsis, severe adhesive disease, incarceration.Post-operative patient treatment included revision surgery, placement of wound vac, lysis of adhesions, exploratory laparotomy, resection of end ileostomy, abdominal washout, medication.
 
Additional Manufacturer Narrative
Additional info: b5, b7, h6 (patient codes).Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PARIETEX
Common Device Name
MESH, SURGICAL, POLYMERIC
Manufacturer (Section D)
SOFRADIM PRODUCTION SAS
116 avenue du formans
trevoux 01600
FR  01600
Manufacturer (Section G)
SOFRADIM PRODUCTION SAS
116 avenue du formans
trevoux 01600
FR   01600
Manufacturer Contact
mike bocchino
8200 coral sea st ne
8200 coral sea st ne
mounds view, MN 55112-4391
8006464633
MDR Report Key19968283
Report Number9615742-2024-01158
Device Sequence Number15694838
Product Code FTL
UDI-Device Identifier10884521179769
UDI-Public(01)10884521179769(17)220930(10)PRJ0154X
Combination Product (Y/N)N
Initial Reporter StateMA
Initial Reporter CountryUS
PMA/510(K) Number
K173796
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2018
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Consumer
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup,Followup
Report Date (Section B) 07/02/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date09/30/2022
Device Model NumberPCO2015X
Device Catalogue NumberPCO2015X
Device Lot NumberPRJ0154X
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/31/2024
Supplement Date Received by Manufacturer12/03/2025
07/01/2026
Initial Report FDA Received Date08/12/2024
Supplement Report FDA Received Date12/05/2025
07/02/2026
Date Device Manufactured11/09/2017
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Disability; Required Intervention; Life Threatening;
Patient SexFemale
Patient Weight190 LB
-
-